J. Winer

发表

The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis

S. Sa, P. Valdez, Jianfeng Wu, 2007, The Journal of Immunology.

Prostaglandin F2 alpha induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo.

J. Winer, H. Jin, R. Yang, 1996, The American journal of physiology.

In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set.

Franklin Peale, Thomas D. Wu, Thomas D Wu, 2002, Physiological genomics.

Endogenous cardiac vasoactive factors modulate endothelin production by cardiac fibroblasts in culture

J. Winer, K. King, J. Mather, 1996, Endocrine.

Development and Application of Real-Time Quantitative PCR

J. Winer, P. Williams, C. Heid, 1998 .

Aortic smooth muscle cells express and secrete vascular endothelial growth factor.

J. Winer, N. Ferrara, T. Burton, 1991, Growth factors.

Solubilization of a guanine nucleotide-sensitive parathyroid hormone-receptor complex from canine renal cortex.

J. Winer, R. Nissenson, E. Mann, 1986, Endocrinology.

Solubilization of a guanine nucleotide-sensitive parathyroid hormone-receptor complex from canine renal cortex.

J. Winer, R. Nissenson, E. Mann, 1986, Advances in experimental medicine and biology.

Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro.

J. Winer, P. Williams, C. Jung, 1999, Analytical biochemistry.

Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells.

J. Winer, N. Ferrara, W. Henzel, 1991, Methods in enzymology.

Phenylephrine, endothelin, prostaglandin F2α, and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro, and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro

J. Winer, P. Williams, D. Phillips, 1998, Endocrine.

Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor.

J. Winer, N. Ferrara, W. Henzel, 1992, Proceedings of the National Academy of Sciences of the United States of America.

The effect of renal function on changes in circulating concentrations of 1,25-dihydroxycholecalciferol after an oral dose.

J. Winer, T. Clemens, S. Papapoulos, 1982, Clinical science.

Covalent labeling of a high-affinity, guanyl nucleotide sensitive parathyroid hormone receptor in canine renal cortex.

J. Winer, D. Karpf, R. Nissenson, 1987, Biochemistry.

Structural properties of the renal parathyroid hormone receptor: hydrodynamic analysis and protease sensitivity.

J. Winer, D. Karpf, R. Nissenson, 1988, Endocrinology.

The canine renal parathyroid hormone receptor is a glycoprotein: characterization and partial purification.

J. Winer, D. Karpf, R. Nissenson, 1987, Biochemistry.

Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.

J. Winer, J. Park, N. Ferrara, 1994, The Journal of biological chemistry.

Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues.

J. Winer, N. Ferrara, L. Jakeman, 1992, The Journal of clinical investigation.

The vascular endothelial growth factor family of polypeptides

J. Winer, N. Ferrara, L. Jakeman, 1991, Journal of cellular biochemistry.

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Bing Li, Napoleone Ferrara, J. Winer, 1993, Nature.

Chapter 2.2.4 Application of real-time RT-PCR for quantification of gene expression

J. Winer, P. Williams, R. Gerlai, 1999 .

A blockade in Wnt signaling is activated following the differentiation of F9 teratocarcinoma cells.

J. Winer, Mickey P. Williams, P. Polakis, 2004, Experimental cell research.

Cardiac fibroblasts produce leukemia inhibitory factor and endothelin, which combine to induce cardiac myocyte hypertrophy in vitro

J. Winer, P. Williams, J. Hooley, 1996, Endocrine.

The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

J. Winer, B. Li, N. Ferrara, 1991, Molecular endocrinology.

Regulation of Learning by EphA Receptors: a Protein Targeting Study

J. Winer, H. Phillips, R. Gerlai, 1999, The Journal of Neuroscience.

The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies.

J. Winer, B. Li, N. Ferrara, 1992, Growth factors.

Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells.

J. Winer, H. Phillips, A. Rowland, 1993, The Journal of clinical investigation.

Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.

J. Winer, A. Rowland, N. Ferrara, 1992, The Journal of biological chemistry.

Synergistic Induction of Tumor Antigens by Wnt-1 Signaling and Retinoic Acid Revealed by Gene Expression Profiling*

J. Winer, P. Williams, P. Polakis, 2002, The Journal of Biological Chemistry.

Chapter 3.2.7 Protein targeting in the functional analysis of EphA receptors: the use of immunoadhesins

J. Winer, H. Phillips, P. Williams, 1999 .

Phenylephrine, endothelin, prostaglandin F2alpha' and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro.

J. Winer, P. Williams, D. Phillips, 1998, Endocrine.

Photoaffinity labeling of the canine renal receptor for parathyroid hormone.

J. Winer, R. Nissenson, C. Arnaud, 1982, The Journal of biological chemistry.